Status
Conditions
Treatments
About
The work carried out at the Brest University Hospital on serum immunological changes in patients with polymyalgia rheumatica (PMR) (based on clinical protocols TENOR, SEMAPHORE, THEN) made it possible to describe the changes in the distribution of lymphocyte subpopulations and cytokine levels during PPR, before and then under treatment compared to controls.
However, in systemic autoimmune or inflammatory pathologies, serum immunological mechanisms are rarely a reflection of intra-tissue mechanisms.
In the specific case of PMR, there are few data concerning muscular or joint immunological modifications. The investigators now wish to study the immunological modifications occurring at the tissue sites of interest, in particular in the shoulder bursae
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
For everyone :
Inclusion criteria :
For case patients:
For witnesses:
Exclusion criteria :
For everyone :
For the cases:
For witnesses:
Primary purpose
Allocation
Interventional model
Masking
20 participants in 2 patient groups
Loading...
Central trial contact
Valérie Devauchelle-Pensec, PUPH
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal